vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Simulations Plus, Inc. (SLP). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $18.4M, roughly 1.3× Simulations Plus, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -2.7%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs 0.3%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

ADCT vs SLP — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.3× larger
ADCT
$23.1M
$18.4M
SLP
Growing faster (revenue YoY)
ADCT
ADCT
+39.0% gap
ADCT
36.4%
-2.7%
SLP
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
0.3%
SLP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ADCT
ADCT
SLP
SLP
Revenue
$23.1M
$18.4M
Net Profit
$676.0K
Gross Margin
59.1%
Operating Margin
-77.7%
3.9%
Net Margin
3.7%
Revenue YoY
36.4%
-2.7%
Net Profit YoY
228.2%
EPS (diluted)
$0.04
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
SLP
SLP
Q4 25
$23.1M
$18.4M
Q3 25
$15.8M
$17.5M
Q2 25
$18.1M
$20.4M
Q1 25
$17.4M
$22.4M
Q4 24
$16.9M
$18.9M
Q3 24
$18.0M
$18.7M
Q2 24
$17.0M
$18.5M
Q1 24
$17.8M
$18.3M
Net Profit
ADCT
ADCT
SLP
SLP
Q4 25
$676.0K
Q3 25
$-41.0M
$-681.0K
Q2 25
$-56.6M
$-67.3M
Q1 25
$-38.6M
$3.1M
Q4 24
$206.0K
Q3 24
$-44.0M
$843.0K
Q2 24
$-36.5M
$3.1M
Q1 24
$-46.6M
$4.0M
Gross Margin
ADCT
ADCT
SLP
SLP
Q4 25
59.1%
Q3 25
56.4%
Q2 25
64.0%
Q1 25
58.5%
Q4 24
54.0%
Q3 24
36.6%
Q2 24
71.5%
Q1 24
72.2%
Operating Margin
ADCT
ADCT
SLP
SLP
Q4 25
-77.7%
3.9%
Q3 25
-196.6%
3.8%
Q2 25
-244.1%
-364.5%
Q1 25
-163.5%
12.1%
Q4 24
-191.8%
0.7%
Q3 24
-197.4%
-6.2%
Q2 24
-170.5%
10.1%
Q1 24
-188.3%
24.3%
Net Margin
ADCT
ADCT
SLP
SLP
Q4 25
3.7%
Q3 25
-260.1%
-3.9%
Q2 25
-313.2%
-330.6%
Q1 25
-221.8%
13.7%
Q4 24
1.1%
Q3 24
-244.1%
4.5%
Q2 24
-214.6%
16.9%
Q1 24
-261.1%
22.0%
EPS (diluted)
ADCT
ADCT
SLP
SLP
Q4 25
$0.04
$0.03
Q3 25
$-0.30
$-0.03
Q2 25
$-0.50
$-3.35
Q1 25
$-0.36
$0.15
Q4 24
$-0.26
$0.01
Q3 24
$-0.42
$0.04
Q2 24
$-0.38
$0.15
Q1 24
$-0.56
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
SLP
SLP
Cash + ST InvestmentsLiquidity on hand
$261.3M
$35.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$127.1M
Total Assets
$323.1M
$137.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
SLP
SLP
Q4 25
$261.3M
$35.7M
Q3 25
$234.7M
$32.4M
Q2 25
$264.6M
$28.4M
Q1 25
$194.7M
$21.4M
Q4 24
$250.9M
$18.2M
Q3 24
$274.3M
$20.3M
Q2 24
$300.1M
$119.0M
Q1 24
$234.3M
$108.5M
Stockholders' Equity
ADCT
ADCT
SLP
SLP
Q4 25
$-185.8M
$127.1M
Q3 25
$-238.2M
$124.8M
Q2 25
$-199.2M
$123.8M
Q1 25
$-238.2M
$189.5M
Q4 24
$-202.6M
$184.7M
Q3 24
$-171.9M
$182.4M
Q2 24
$-131.7M
$180.9M
Q1 24
$-194.4M
$177.0M
Total Assets
ADCT
ADCT
SLP
SLP
Q4 25
$323.1M
$137.8M
Q3 25
$289.8M
$131.9M
Q2 25
$321.6M
$134.4M
Q1 25
$272.5M
$201.4M
Q4 24
$322.0M
$196.9M
Q3 24
$349.1M
$196.6M
Q2 24
$371.8M
$192.7M
Q1 24
$308.0M
$194.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
SLP
SLP
Operating Cash FlowLast quarter
$-31.1M
$4.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
6.26×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
SLP
SLP
Q4 25
$-31.1M
$4.2M
Q3 25
$-29.6M
$5.6M
Q2 25
$-24.1M
$8.1M
Q1 25
$-56.3M
$5.7M
Q4 24
$-21.9M
$-1.3M
Q3 24
$-25.0M
$1.7M
Q2 24
$-32.8M
$5.7M
Q1 24
$-44.1M
$5.8M
Free Cash Flow
ADCT
ADCT
SLP
SLP
Q4 25
Q3 25
$5.3M
Q2 25
$7.8M
Q1 25
$-56.6M
$5.6M
Q4 24
$-21.9M
$-1.4M
Q3 24
$-25.3M
$1.6M
Q2 24
$-32.9M
$5.6M
Q1 24
$-44.6M
$5.4M
FCF Margin
ADCT
ADCT
SLP
SLP
Q4 25
Q3 25
30.5%
Q2 25
38.5%
Q1 25
-325.2%
25.0%
Q4 24
-129.8%
-7.2%
Q3 24
-140.2%
8.8%
Q2 24
-193.0%
30.0%
Q1 24
-250.0%
29.4%
Capex Intensity
ADCT
ADCT
SLP
SLP
Q4 25
0.0%
0.0%
Q3 25
0.0%
1.5%
Q2 25
0.0%
1.5%
Q1 25
1.5%
0.3%
Q4 24
0.5%
0.5%
Q3 24
1.2%
0.1%
Q2 24
0.2%
0.6%
Q1 24
3.0%
2.4%
Cash Conversion
ADCT
ADCT
SLP
SLP
Q4 25
6.26×
Q3 25
Q2 25
Q1 25
1.84×
Q4 24
-6.18×
Q3 24
1.97×
Q2 24
1.81×
Q1 24
1.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

SLP
SLP

Services Segment$9.5M52%
Development$7.2M39%
Discovery$1.3M7%

Related Comparisons